Form 4: Leggett & Platt Executive Ryan Michael Kleiboeker Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Ryan Michael Kleiboeker, EVP-Chief Strategic Plan. Off. of Leggett & Platt Inc, reports acquisition of company stock through transactions on February 7, 2025.

Summary

  • On February 7, 2025, Ryan Michael Kleiboeker, an EVP-Chief Strategic Plan. Off. at Leggett & Platt Inc, acquired company stock through transactions.
  • Kleiboeker acquired 83.2524 shares at $8.483 per share and 192.6929 shares at $7.984 per share.
  • Following these transactions, Kleiboeker directly owns 58,026.7652 shares of Leggett & Platt Inc.
  • Kleiboeker also indirectly owns 1,000 shares through a spouse's IRA and 851.985 shares held in trust under the issuer's retirement plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating stock transactions by an executive. The purchase could be seen as slightly positive, but it's not a major event.

Positives

  • The executive's purchase of company stock could be interpreted as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The stock purchase by an executive may have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
02/07/2025Date of stock transactions.
02/10/2025Date of signature by attorney-in-fact.

Keywords

Leggett & Platt, Kleiboeker, stock acquisition, Form 4, insider trading, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.